ArticleJCEM case reports2026
Cardiac Tamponade, Pituitary Hyperplasia, and Macroorchidism in Severe Primary Hypothyroidism.
Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case reports a rare and complex presentation of severe primary hypothyroidism (PH) in an 18-year-old male. The patient presented to the emergency department with dyspnea due to impending cardiac tamponade, requiring emergency pericardiocentesis. Further evaluation revealed features of long-standing PH, including short stature, cognitive delay, and pubertal discordance with macroorchidism. Laboratory tests showed extreme elevation of TSH and multiple anterior pituitary hormone deficiencies. Magnetic resonance imaging (MRI) revealed a large sellar mass mimicking a pituitary adenoma. Treatment was initiated with levothyroxine and physiological hydrocortisone. Follow-up at 6 months showed improvement in clinical status and TSH level and significant regression of the pituitary mass on repeat MRI, confirming the diagnosis of pituitary hyperplasia in primary hypothyroidism (PHPH). This case highlights the potential for severe, life-threatening manifestations of PH and emphasizes that a therapeutic trial with levothyroxine is the definitive approach to differentiate PHPH from a TSH-secreting pituitary adenoma, thus avoiding unnecessary surgical intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.